Treatment Options During Perimenopause: The Complete Overview

Educational only. Not medical advice. Treatment selection depends on your specific symptoms, severity, medical history, and preferences. This guide provides a framework for a conversation with your clinician, not a prescription.

The perimenopause treatment landscape is broader than most women realize. The conversation often jumps straight to “should I take hormones?” when the real question is “what is the right intervention for MY symptoms at THIS stage of my transition?”

For some women, lifestyle modifications are sufficient. For others, hormonal treatment is clearly indicated. Many land somewhere in the middle. The key is matching the intervention to the symptom severity, the woman’s risk profile, and the stage of the transition.

Vasomotor symptoms (hot flashes, night sweats).

Mild (occasional, not disrupting function): lifestyle modifications (layered clothing, cool environment, trigger avoidance - alcohol, caffeine, spicy food for some women), regular exercise (reduces frequency and severity in some studies), stress management (CBT-M has RCT evidence for hot flash reduction).

Moderate (regular, affecting sleep and daily function): low-dose OCP (if also needing contraception), cyclic HRT, non-hormonal medications (SSRIs/SNRIs - paroxetine 7.5mg is FDA-approved as Brisdelle for vasomotor symptoms. Venlafaxine and desvenlafaxine are also used off-label), gabapentin (particularly useful if hot flashes are worst at night because the sedative effect helps sleep), fezolinetant (Veozah). NK3 receptor antagonist, FDA approved 2023, first non-hormonal medication specifically designed for vasomotor symptoms).

Severe (multiple daily, significantly impairing): HRT is the most effective treatment. Nothing else matches its efficacy for severe vasomotor symptoms. If HRT is contraindicated, combining two non-hormonal approaches (such as an SSRI, gabapentin, and lifestyle changes) may provide partial relief.

Mood symptoms (anxiety, depression, irritability).

Emerging with perimenopause, no prior history: trial HRT first. Hormonally-driven mood changes often respond to hormonal stabilization. If insufficient after 8 to 12 weeks, add an SSRI or SNRI.

Pre-existing mood disorder worsening during perimenopause: optimize current psychiatric treatment AND consider HRT for hormonal stabilization. The combination often works better than either alone.

Severe (suicidal ideation, functional impairment): psychiatric treatment first, HRT as adjunct. Do not delay appropriate psychiatric care while trialing HRT.

Sleep disruption.

Primarily from night sweats: HRT (addresses the cause). Improvement often within 2-4 weeks.

Primarily insomnia (not sweat-related): sleep hygiene optimization, CBT for insomnia (CBT-I, strongest evidence for chronic insomnia), consider progesterone at bedtime (natural sedative effect via allopregnanolone metabolite), evaluate for sleep apnea (risk increases after menopause).

Vaginal and urinary symptoms.

Any severity: vaginal estrogen is first-line. It is local therapy with minimal systemic absorption, effective, and can be used alongside systemic HRT or alone. OTC moisturizers (Replens, Hyalo GYN) and lubricants provide symptomatic relief but do not treat the underlying tissue atrophy. Pelvic floor therapy for urinary urgency and incontinence.

Heavy or irregular bleeding.

See the heavy periods guide for the full framework. Key options: Mirena IUD (most effective for bleeding reduction + endometrial protection), cyclic progestogen therapy, low-dose OCP, tranexamic acid during heavy episodes.

Cognitive symptoms (brain fog, memory, concentration).

HRT may help if symptoms correlate with other perimenopausal symptoms. Exercise has independent cognitive benefits. Adequate sleep is essential (sleep deprivation alone causes cognitive impairment). If symptoms persist despite addressing hormones and sleep, evaluate for other causes (thyroid, B12, depression, ADHD).

The hardest decision in perimenopause management is not which treatment to choose - it is when to acknowledge that lifestyle modifications alone are not enough. Many women - and many clinicians - default to “try lifestyle changes first” as a way to delay pharmacological treatment. For mild symptoms, this is appropriate. For moderate-to-severe symptoms, it is a delay that costs quality of life.

The escalation signal: if you have optimized sleep hygiene, exercise regularly, manage stress actively, and have modified dietary triggers, and your symptoms still significantly affect your work, relationships, sleep, or daily functioning after 4 to 8 weeks of consistent effort, it is time for pharmacological treatment. Lifestyle modifications remain the foundation - they support whatever medication you add. But they are not a substitute for medication when symptoms are moderate or severe.

The women who delay treatment longest are often the ones most committed to “doing it naturally.” That commitment is admirable. But there is nothing unnatural about replacing hormones that your body stopped producing prematurely. HRT for perimenopause is not a failure of lifestyle management. It is a medical treatment for a medical condition.

Step 1: identify your most disruptive symptoms. Step 2: assess severity (mild, moderate, severe). Step 3: check contraindications and risk factors. Step 4: match intervention to symptoms and severity. Step 5: evaluate response at 8 to 12 weeks. Step 6: adjust - add, switch, or escalate based on response.

This is iterative. The first approach may not be the final approach. A good clinician adjusts based on your response rather than prescribing a fixed protocol and hoping it works.

• What are my most significant symptoms, and what is the most effective treatment for each?
• Given my risk profile, which options are available to me?
• Should we address the most disruptive symptom first, or take a comprehensive approach?
• What is the expected timeline for improvement, and when should we reassess?
• If the first approach does not work, what is the next step?